glp 1 agonist parkinson Repurposing GLP-1 Receptor Agonists for Parkinson's Disease: Current Evidence and Future Opportunities | Pharmaceutical Medicine Mechanisms by which GLP-1 agonists
Description
7, July 2015, pp
The primers used are summarized in Supplementary Table 6
Kong HH, Won CW, Kim W
However, this perspective has shifted with the development of new, highly effective drugs that are safe and accessible for a wider population
Bode BW, Testa MA, Magwire M, et al
GLP-1 receptor agonists are transforming obesity treatment
